Drug Database
Back to search

Poland· PL-100128487

Ulgix Laxi

A docusate sodium product containing natrii docusas, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 5 of our 19 countries.

ATC A06AA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedUlgix LaxiATCA06AA02REGISTER NO.PL-100128487PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about natrii docusasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Docusate sodium is registered in 5 of 19 countries.

Countries holding a registration under ATC A06AA02 (docusate sodium), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search docusate sodium products by name

Docusate sodium · ATC A06AA02

5 / 19 countries

  • Canada
  • Japan
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Natrii docusas
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
A06AA02
ATC class
Docusate sodium
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991089818
  • gtin
    05904055004073

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for docusate sodium.

Graded by severity as the source publishes them — 3 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check docusate sodium against other medicinesHow interaction checks work

Docusate sodium · interactions on record

4 records

  • 3 moderate
  • 1 minor

Most severe, free to view

  • Liquid paraffinA06AA01moderate
  • PhenolphthaleinA06AB04moderate
  • LactuloseA06AD11moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Docusate sodium in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All docusate sodium products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Norgalax
  • France · Jamylene, Norgalax
  • United Kingdom (Northern Ireland) · Dioctyl, Docusate Sodium Adult Typharm
  • Ireland · Waxsol
  • Luxembourg · Norgalax
  • Netherlands · Norgalax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9696450a-3a2e-4bcb-bd9c-b598532f9018
GET /v1/drugs/9696450a-3a2e-4bcb-bd9c-b598532f9018?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki miękkie",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909991089818 ¦ OTC ¦ 24600\n30 kaps.\n05904055004073 ¦ OTC ¦ 117110\n15 kaps.",
  "substance": "Natrii docusas 50 mg",
  "common_name": "Natrii docusas",
  "pl_product_id": "100128487",
  "pozwolenie_nr": "10898",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about docusate sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console